McClellan To Lead June 13 CMS Forum On Drug Data Strategies
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA and AHRQ officials will discuss ways Medicare data could help improve medical decisions. The Drug Data Strategy plan combines Part D drug data with Parts A and B medical treatment data.